Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009
- PMID: 27704009
- PMCID: PMC5047430
- DOI: 10.1093/ofid/ofw152
Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009
Abstract
In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation cephalosporins. Consideration of current practices may inform future meningococcal disease management guidelines.
Keywords: Neisseria meningitidis; antimicrobial resistance; meningitis; meningococcal disease.
Similar articles
-
Practice patterns of infectious disease physicians for management of meningococcal disease.Pediatr Infect Dis J. 2012 Nov;31(11):e208-12. doi: 10.1097/INF.0b013e31826323a4. Pediatr Infect Dis J. 2012. PMID: 22705919
-
Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.Open Forum Infect Dis. 2015 Aug 13;2(3):ofv117. doi: 10.1093/ofid/ofv117. eCollection 2015 Sep. Open Forum Infect Dis. 2015. PMID: 26357666 Free PMC article.
-
[Neisseria meningitidis with a decreased sensitivity to penicillin in the Zagreb District].Lijec Vjesn. 2001 Sep-Oct;123(9-10):231-3. Lijec Vjesn. 2001. PMID: 11845576 Croatian.
-
Meningococcal disease: history, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and prevention.Indian J Med Microbiol. 2006 Jan;24(1):7-19. doi: 10.4103/0255-0857.19888. Indian J Med Microbiol. 2006. PMID: 16505549 Review.
-
Emergence and spread of resistant N. meningitidis implicated in invasive meningococcal diseases during the past decade (2008-2017).J Antibiot (Tokyo). 2019 Mar;72(3):185-188. doi: 10.1038/s41429-018-0125-0. Epub 2018 Nov 27. J Antibiot (Tokyo). 2019. PMID: 30479393 Review.
Cited by
-
Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016.J Infect Dis. 2022 Jun 1;225(11):1871-1875. doi: 10.1093/infdis/jiac046. J Infect Dis. 2022. PMID: 35266516 Free PMC article.
-
Detection of Ciprofloxacin-Resistant, β-Lactamase-Producing Neisseria meningitidis Serogroup Y Isolates - United States, 2019-2020.MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):735-739. doi: 10.15585/mmwr.mm6924a2. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32555137 Free PMC article.
References
-
- Tunkel A, Scheld W. Acute meningitis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed Philadelphia: Churchill Livingstone; 2005: pp 2476.
-
- Tunkel AR, Hartman BJ, Kaplan SL et al. . Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267–84. - PubMed
-
- American Academy of Pediatrics. Meningococcal infections. In: Jackson MA, Kimberlin D, eds. Red Book 2015: Report of the Committee on Infectious Diseases. 30th ed Elk Grove Village, IL: American Academy of Pediatrics; 2015: pp 547–58.
-
- Centers for Disease Control and Prevention. Active Bacterial Core surveillance (ABCs). Available at: www.cdc.gov/abcs/overview/index.html Accessed 22 August 2012.
-
- CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document M100-S25 ed Wayne, PA: Clinical and Laboratory Standards Institute; 2015.
LinkOut - more resources
Full Text Sources
Other Literature Sources

